Medline Industries recalled 828 units of catheter kits on August 21, 2025, due to potential shape retention issues. The affected products include Model Numbers DYNJ0415366P and DYNJ0415366Q. This recall poses a serious risk to patient safety.
The kits contain certain lots of cannula products where the catheter may not retain its shape.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medline Industries, LP or your healthcare provider for instructions. Notification method: Letter
The recall includes 828 units of VALVE PACK-LF kits with Model Numbers DYNJ0415366P and DYNJ0415366Q. These kits were distributed nationwide, particularly in California.
The catheter in these kits may not retain its shape, which can compromise medical procedures. The hazard classification is Class I, indicating a high risk.
There are no reported incidents or injuries associated with this recall at this time. However, the potential risk to patient safety remains high.
Patients and healthcare providers should stop using these kits immediately. Contact Medline Industries or your healthcare provider for further instructions.
For more information, contact Medline Industries at 1-800-XXXX-XXXX or visit their website at www.medline.com.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.